Target Name: GPR78
NCBI ID: G27201
Other Name(s): GPR78 variant 1 | G-protein coupled receptor 78 | G protein-coupled receptor 78, transcript variant 1 | G protein-coupled receptor 78 | GPR78_HUMAN

Understanding GPR78: A Potential Drug Target and Biomarker for Various Diseases

GPR78 (G protein-coupled receptor 78) is a G protein-coupled receptor that is expressed in various tissues and cells in the body. It is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. GPR78 has also been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

GPR78 is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling. GPCR is characterized by the presence of a catalytic G protein, which can interact with intracellular signaling molecules to regulate various cellular processes. The GPCR family includes over 700 different genes, and many of these genes have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

GPR78 is a non-coding RNA molecule that is expressed in various tissues and cells in the body. It is characterized by the presence of a unique extracellular domain that is composed of a nucleotide-binding oligomerization (NBO) domain and a leucine-rich repeat (LRR) domain. The NBO domain is a transmembrane protein that is involved in the formation of the N-terminus of the RNA molecule. The LRR domain is a protein-coding domain that is involved in the regulation of gene expression.

GPR78 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. It is expressed in various tissues and cells in the body, including the brain, spinal cord, and peripheral tissues. Regulation of a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

GPR78 has also been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, GPR78 has been shown to be involved in the regulation of pain perception, and may be a potential drug target for the treatment of chronic pain. Additionally, GPR78 has been shown to be involved in the regulation of neurotransmitter signaling, and may be a potential drug target for the treatment of neurodegenerative diseases.

GPR78 is also a potential biomarker for certain psychiatric disorders, such as depression and anxiety. Studies have shown that GPR78 is involved in the regulation of mood and anxiety, and may be a potential biomarker for these disorders. Additionally, GPR78 has been shown to be involved in the regulation of social behavior, and may be a potential biomarker for certain psychiatric disorders, such as schizophrenia.

GPR78 is also a potential drug target for the treatment of cancer, neurodegenerative diseases, and psychiatric disorders. For example, GPR78 has been shown to be involved in the regulation of cell growth and survival, and may be a potential drug target for the treatment of cancer. Additionally, GPR78 has been shown to be involved in the regulation of neurotransmitter signaling, and may be a potential drug target for the treatment of neurodegenerative diseases. It may also be a potential biomarker for certain psychiatric disorders, such as depression and anxiety.

In conclusion, GPR78 is a non-coding RNA molecule that is involved in a wide range of physiological processes. It is a member of the G protein-coupled receptor family and has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the role of GPR78 in

Protein Name: G Protein-coupled Receptor 78

Functions: Orphan receptor. Displays a significant level of constitutive activity. Its effect is mediated by G(s)-alpha protein that stimulate adenylate cyclase, resulting in an elevation of intracellular cAMP

More Common Targets

GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2 | GRIA3 | GRIA4 | GRID1 | GRID2 | GRID2IP | GRIFIN | GRIK1 | GRIK1-AS1 | GRIK1-AS2 | GRIK2 | GRIK3 | GRIK4 | GRIK5 | GRIN1 | GRIN2A | GRIN2B | GRIN2C | GRIN2D | GRIN3A | GRIN3B | GRINA | GRIP1 | GRIP2 | GRIPAP1 | GRK1 | GRK2 | GRK3